Patient's Query
Hello doctor,
My grandmother just discovered she has metastatic breast cancer. The original diagnosis was 15 years ago; we thought she was clear. Now it is in her bones and liver. Her previous tumor was ER/PR-positive, HER2-negative. The current PET scan shows multiple bone lesions. How did this happen after so long? What treatment options exist for metastatic spread? Her age is 78 years, which complicates everything. Can she handle aggressive treatment? What is the typical survival rate for her situation? Her bone density scan shows severe osteoporosis, and she is diabetic. How will these impact her cancer treatment?
Kindly help.
Thank you.
Hello,
Welcome to icliniq.com.
I read your query and understood your concern.
I am sorry to hear about your grandmother’s diagnosis. Discovering metastatic breast cancer after many years of being in remission is very challenging. Here is a detailed look at her situation and potential treatment options:
Understanding metastatic breast cancer after long-term remission:
Metastatic breast cancer years after remission: The return of breast cancer many years after an initial diagnosis is relatively rare but not unheard of. This could be due to dormant cancer cells that were present but not detected at the time of the original diagnosis, which then reactivated due to changes in her health status, such as age, hormonal changes, or other factors that may have weakened her immune system.
Trigger factors: Factors such as aging, changes in hormone levels, or other underlying conditions like diabetes could have contributed to the reactivation of the cancer cells.
Treatment options are as follows:
Systemic therapy:
Hormone therapy: For estrogen receptor/progesterone receptor (ER/PR) positive cancer: Given her original tumor was ER/PR positive, hormone therapy is likely a primary treatment option. Medications such as aromatase inhibitors (if not already used), selective estrogen receptor modulators (SERMs) like Tamoxifen, or luteinizing hormone-releasing hormone (LHRH) agonists could be considered depending on her current hormonal status and overall health.
Chemotherapy: For human epidermal growth factor receptor 2 (HER2) negative: Chemotherapy can be an option if hormone therapy alone is not sufficient. It may involve drugs such as Capecitabine, Methotrexate, or Anthracyclines, depending on her condition and prior treatments.
Targeted therapy: For HER2 negative: While HER2-negative cancers generally do not respond to targeted therapies such as Trastuzumab, there are newer targeted therapies being developed for this subtype.
Bone-directed therapy: For bone metastases, Medications such as Bisphosphonates (e.g., zoledronic acid) or Denosumab are used to strengthen bone and reduce the risk of fractures, which is particularly important given her osteoporosis. These treatments can help manage bone pain and reduce the progression of bone lesions.
Liver-directed therapy: If liver metastases are significant, targeted treatments such as local therapies (radiofrequency ablation or transarterial chemoembolization -TACE) might be considered, although these are generally used in combination with systemic treatments.
Palliative care:
Symptom management: Given her age and the complexity of her health issues (severe osteoporosis, diabetes), palliative care is crucial. This involves managing symptoms such as pain, nausea, and fatigue, and maintaining her quality of life. Pain management could involve bone-modifying agents or targeted pain relief therapies.
Supportive care: Care from a multidisciplinary team, including oncologists, geriatric specialists, and palliative care providers, is essential to address her physical, emotional, and social needs.
Considerations due to comorbidities:
Osteoporosis:
Impact on treatment: Severe osteoporosis complicates bone metastases treatment. Some cancer therapies can weaken bones further or increase the risk of fractures, so managing bone density is crucial. Bisphosphonates and Denosumab are often used for this purpose.
Monitoring: Regular bone density scans and monitoring for fractures or bone pain are essential.
Diabetes:
Impact on treatment: Diabetes can complicate cancer treatment due to its impact on blood sugar regulation and wound healing. Her blood glucose levels will need to be closely monitored during chemotherapy to avoid complications.
Insulin management: Adjustments to her insulin regimen might be necessary during periods of high stress or when undergoing chemotherapy.
Age-related considerations:
Risk tolerance: At seventy-eight, aggressive treatments may not be suitable if they significantly impact her quality of life. However, she may still be a candidate for certain treatments if they can extend survival and maintain her comfort.
Geriatric oncology: A geriatric assessment could help determine her ability to tolerate treatment. This evaluation looks at overall health, functional status, and cognitive ability, ensuring that the treatment plan is tailored to her capabilities.
Survival and prognosis:
Prognosis: Survival in metastatic breast cancer varies widely based on factors such as overall health, prior treatments, and response to therapy. For her situation, survival could range from months to several years, depending on how she responds to treatment and her ability to tolerate it.
Median survival: The median survival for metastatic breast cancer can vary. For those over seventy, the median survival is about two to three years, but it depends on how the cancer responds to treatment and her overall health.
Quality of life: Focusing on maintaining a good quality of life and managing symptoms should be a priority. Regular check-ups and follow-up imaging to monitor the cancer’s progression are crucial.
Suggested next steps are as follows:
Consult with a multidisciplinary team: Her treatment should be discussed with a team of specialists, including an oncologist, geriatrician, palliative care expert, and possibly a radiologist to discuss options for bone and liver metastases.
Personalized treatment plan: A personalized plan, considering her health conditions and personal goals, can help manage her cancer effectively while also addressing her other medical needs.
Support: Ensuring that she has strong emotional and psychological support from family and possibly a counselor or support group for cancer patients can be invaluable during this challenging time.
Facing metastatic breast cancer after a long period of remission is incredibly daunting. It is important to focus on the quality of her remaining life, manage symptoms, and consider both her and her family’s needs in the treatment plan.
I hope this helps.
Please let us know if you have any further queries. We would be happy to answer.
Thank you.
Was this conversation helpful?
Answered byDr. Prabhakaran
Medically reviewed byiCliniq medical review team
Same symptoms don't mean you have the same problem. Consult a doctor now!
Related Questions
What are the common side effects of hormone therapy?
Breast Cancer and Hormonal Birth Control: Is There a Risk?
Understanding Long Term Care for Geriatric Patients
The Barthel Index - A Crucial Tool in Assessing Functional Independence
Breast Cancer Recurrence: Causes, Symptoms, Risk Factors, and Prevention
What is HER2-negative breast cancer?
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.